Latest Headlines

• January 14, 2009 - News Release
  Government of Canada Works to Improve Knowledge About the Safety and Effectiveness of Drugs
  The Honourable Leona Aglukkaq, Minister of Health, today announced that the Government of Canada is continuing to support the Drug Safety and Effectiveness Network (DSEN), first announced in July 2008.
• January 13, 2009 - Information Update
  New Safety Information Regarding Botox
  Health Canada is informing Canadians and Canadian health care professionals that the labelling information of BOTOX ® and BOTOX Cosmetic ® will now include the risk of the toxin spreading to other distant parts of the body. Possible symptoms of “distant toxin spread,” which can be fatal, include muscle weakness, swallowing difficulties, pneumonia, speech disorders and breathing problems.
• January 6, 2009 - Information Update
  Important Safety Information for the Smoking-Cessation Aid Champix
  Health Canada is reminding Canadians who are taking, or considering taking, the smoking-cessation aid Champix of important safety information for this product. Health Canada is also informing Canadians that it is in the process of further strengthening the labelling for the drug with respect to the risk of serious psychiatric adverse effects.
• Media Room

Highlights

• Canadian Adverse Reaction Newsletter - January 2009 edition
• Careers at Health Canada
• Sun Safety
• Melamine in Food Products
• Listeria and Food Safety

Print | Need Larger Text?